, Symptômes dépressifs
, IMC : Indice de la masse corporelle
, Les variables catégorielles sont décrites avec des pourcentages, alors que les variables continues sont décrites avec des moyennes ± écart-types. Références 1. Espérance de vie -Mortalité ? Tableaux de l'économie française | Insee
, mentation 2. Association AP. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®)
, American Psychiatric Pub, 2019.
, Maladie d'Alzheimer et autres démences
, , 2019.
, Dementia
Dementia prevention, intervention, and care, Lancet, vol.390, pp.2673-734, 2017. ,
Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study, BMJ, vol.332, issue.7539, pp.455-464, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00000025
Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study, JAMA Intern Med, vol.175, issue.3, pp.401-408, 2015. ,
Organization of memory: Quo vadis? In: The cognitive neurosciences, pp.839-53, 1995. ,
Episodic and semantic memory, p.423, 1972. ,
Episodic memory. Current Biology, vol.17, pp.189-91, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-02268035
Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies, Ageing Res Rev, vol.24, pp.232-62, 2015. ,
, , 1999.
Les faux souvenirs : à la frontière du normal et du pathologique, PSYCHOLOGIE & NEUROPSYCHIATRIE DU VIEILLISSEMENT, vol.2, pp.127-161, 2006. ,
,
False memories: What the hell are they for? Applied Cognitive Psychology, vol.23, pp.1105-1126, 2009. ,
Memory--a century of consolidation, Science, vol.287, issue.5451, pp.248-51, 2000. ,
Is memory consolidation a multiple-circuit system?, vol.107, pp.8051-8053, 2010. ,
Sleep-Related Hippocampo-Cortical Interplay during Emotional Memory Recollection. PLOS Biology, vol.5, p.282, 2007. ,
Sleep Loss Produces False Memories, PLOS ONE, vol.3, issue.10, p.3512, 2008. ,
Executive functions, Annu Rev Psychol, vol.64, pp.135-68, 2013. ,
Assessment of executive functions: Review of instruments and identification of critical issues. Archives of Clinical Neuropsychology, vol.23, pp.201-217, 2008. ,
Memory function in normal aging, Neurology, vol.42, issue.2, pp.396-401, 1992. ,
The value of informant versus individual's complaints of memory impairment in early dementia, Neurology, vol.55, issue.11, pp.1724-1730, 2000. ,
, Longitudinal cohort studies in neurodegeneration research, p.92, 2013.
Effect size for the main cognitive function determinants in a large cross-sectional study, Eur J Neurol, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01355388
Sex and the development of Alzheimer's disease, J Neurosci Res, vol.95, issue.1-2, pp.671-80, 201702. ,
Risk profiles for mild cognitive impairment and progression to dementia are gender specific, J Neurol Neurosurg Psychiatry, vol.79, issue.9, pp.979-84, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00294905
Educational Differences in the Prevalence of Dementia and Life Expectancy with Dementia: Changes from 2000 to 2010, J Gerontol B Psychol Sci Soc Sci, vol.73, issue.suppl_1, pp.20-28, 201816. ,
APOE ?4 Increases Risk for Dementia in Pure Synucleinopathies, JAMA Neurol, 2013. ,
, Feb, vol.1, issue.2, pp.223-231
Association between APOE ?4 Allele and Vascular Dementia: The Cache County Study, Dement Geriatr Cogn Disord, vol.29, issue.3, pp.248-53, 2010. ,
,
Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: A meta-analysis, Neuroscience Letters, vol.514, issue.1, pp.6-11, 2012. ,
The apolipoprotein E ?4 allele selectively increases the risk of frontotemporal lobar degeneration in males, J Neurol Neurosurg Psychiatry, vol.77, issue.2, pp.154-162, 2006. ,
ApoE2 and Alzheimer's disease: time to take a closer look, Neural Regen Res, vol.11, issue.3, pp.412-415, 2016. ,
Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis, BMC Public Health, vol.14, p.643, 2014. ,
Systematic Review: Factors Associated With Risk for and Possible Prevention of Cognitive Decline in Later Life, Annals of Internal Medicine, vol.153, issue.3, p.182, 2010. ,
World Alzheimer Report 2014: Dementia and Risk Reduction ,
Cigarette Smoking is a Risk Factor for Alzheimer's Disease: An Analysis Controlling for Tobacco Industry Affiliation, Journal of Alzheimer's Disease, vol.19, issue.2, pp.465-80, 2010. ,
Tobacco use knowledge summaries: tobacco use and dementia ,
Smoking Is Associated with an Increased Risk of Dementia: A Meta-Analysis of Prospective Cohort Studies with Investigation of Potential Effect Modifiers, PLOS ONE, vol.10, issue.3, p.118333, 2015. ,
Heavy Smoking in Midlife and Long-term Risk of Alzheimer Disease and Vascular Dementia, Arch Intern Med, vol.171, issue.4, pp.333-342, 2011. ,
Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study, Arch Gen Psychiatry, vol.69, issue.6, pp.627-662, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00677216
Combined impact of smoking and heavy alcohol use on cognitive decline in early old age: Whitehall II prospective cohort study, Br J Psychiatry, vol.203, issue.2, pp.120-125, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-01153653
Alcohol Consumption as a Risk Factor for Dementia and Cognitive Decline: Meta-Analysis of Prospective Studies. The American Journal of Geriatric Psychiatry, vol.17, pp.542-55, 2009. ,
Alcohol, dementia and cognitive decline in the elderly: a systematic review, Age Ageing, vol.37, issue.5, pp.505-517, 2008. ,
,
Moderate alcohol consumption and cognitive risk ,
, Neuropsychiatric Disease and Treatment, 2011.
Self-Reported Alcohol Consumption and Falls in Older Adults: Cross-Sectional and Longitudinal Analyses of the Cardiovascular Health Study, Journal of the American Geriatrics Society, vol.52, issue.7, pp.1174-1183, 2004. ,
Contribution of Excessive Alcohol Consumption to Deaths and Years of Potential Life Lost in the United States, Prev Chronic Dis, vol.11, 2014. ,
Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders. Biological Psychiatry, vol.67, pp.505-517, 2010. ,
Cognitive Function and Decline in Obesity, vol.30, pp.89-95, 2012. ,
Midlife obesity and dementia: Meta-analysis and adjusted forecast of dementia prevalence in the united states and china, Obesity, vol.21, issue.1, pp.51-56, 2013. ,
Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies, Obesity Reviews, vol.12, issue.5, pp.426-463, 2011. ,
37 Years of Body Mass Index and Dementia: Observations from the Prospective Population Study of Women in Gothenburg, Journal of Alzheimer's Disease, vol.28, issue.1, pp.163-71, 2012. ,
Midand Late-Life Obesity: Risk of Dementia in the Cardiovascular Health Cognition Study, Arch Neurol, vol.66, issue.3, pp.336-378, 2009. ,
Predicting risk of dementia in older adults, Neurology, vol.73, issue.3, pp.173-182, 2009. ,
High adiposity: risk factor for dementia and Alzheimer's disease? Alzheimer's Research & Therapy, vol.5, p.57, 2013. ,
Systematic review of health behavioral risks and cognitive health in older adults. International Psychogeriatrics, vol.22, pp.174-87, 2010. ,
Physical activity and risk of cognitive decline: a meta-analysis of prospective studies, Journal of Internal Medicine, vol.269, issue.1, pp.107-124, 2011. ,
Does physical activity prevent cognitive decline and dementia?: A systematic review and meta-analysis of longitudinal studies, vol.14, p.510, 2014. ,
Physical Exercise as a Preventive or Disease-Modifying Treatment of Dementia and Brain Aging. Mayo Clinic Proceedings, vol.86, pp.876-84, 2011. ,
Aerobic Exercise and Neurocognitive Performance: A Meta-Analytic Review of Randomized Controlled Trials. Psychosomatic Medicine, vol.72, pp.239-52, 2010. ,
A Review of the Effects of Physical Activity and Exercise on Cognitive and Brain Functions in Older Adults, J Aging Res, 2013. ,
Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev, p.5381, 2008. ,
The Mental Activity and eXercise (MAX) Trial: A Randomized Controlled Trial to Enhance Cognitive Function in Older Adults, JAMA Intern Med, vol.173, issue.9, pp.797-804, 2013. ,
Physical activity and functional limitations in older adults: a systematic review related to Canada's Physical Activity Guidelines. International Journal of Behavioral Nutrition and Physical Activity, vol.7, p.38, 2010. ,
Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease: A Randomized Trial, JAMA, vol.300, issue.9, pp.1027-1064, 2008. ,
Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension, Eur Heart J, vol.39, issue.33, pp.3119-3144, 201801. ,
Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies, Internal Medicine Journal, vol.42, issue.5, pp.484-91, 2012. ,
Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies, Journal of Diabetes Investigation, vol.4, issue.6, pp.640-50, 2013. ,
Diabetes and Elevated Hemoglobin A1c Levels Are Associated with Brain Hypometabolism but Not Amyloid Accumulation, J Nucl Med, vol.55, issue.5, pp.759-64, 2014. ,
Modifiable Predictors of Dementia in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis, AJP, 2015. ,
Statins for the prevention of dementia. Cochrane Database Syst Rev, p.3160, 2016. ,
,
Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study, J Stroke Cerebrovasc Dis, vol.21, issue.6, pp.436-480, 2012. ,
Traumatic brain injury and risk of dementia in older veterans, Neurology, vol.83, issue.4, pp.312-321, 2014. ,
Traumatic brain injury may increase risk of young onset dementia, Annals of Neurology, vol.75, issue.3, pp.339-380, 2014. ,
Dementia Resulting From Traumatic Brain Injury, Arch Neurol, vol.69, issue.10, pp.1245-51, 2012. ,
Chronic neuropathologies of single and repetitive TBI: substrates of dementia?, Nature Reviews Neurology, vol.9, issue.4, pp.211-232, 2013. ,
Depression and Risk for Alzheimer Disease: Systematic Review, Meta-analysis, and Metaregression Analysis. Arch Gen Psychiatry, vol.63, pp.530-538, 2006. ,
Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies, The British Journal of Psychiatry, vol.202, issue.5, pp.329-364, 2013. ,
Mid-life versus late-life depressive symptoms and risk of dementia: Differential effects for Alzheimer's disease and vascular dementia, Arch Gen Psychiatry, vol.69, issue.5, pp.493-501, 2012. ,
Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment, Neurology, vol.75, issue.1, pp.27-34, 2010. ,
Late-Life Depression, Mild Cognitive Impairment, and Dementia: Possible Continuum?, The American Journal of Geriatric Psychiatry, vol.18, issue.2, pp.98-116, 2010. ,
Sleep Apnea and the Risk of Dementia: A Population-Based 5-Year Follow-Up Study in Taiwan, PLOS ONE, vol.8, issue.10, p.78655, 2013. ,
Sleep disturbance is associated with incident dementia and mortality, Curr Alzheimer Res, vol.10, issue.7, pp.767-75, 2013. ,
Sleep Fragmentation and the Risk of Incident Alzheimer's Disease and Cognitive Decline in Older Persons, Sleep, vol.36, issue.7, pp.1027-1059, 2013. ,
Sleep-disordered breathing advances cognitive decline in the elderly, Neurology, vol.84, pp.1964-71, 2015. ,
The complex interaction between anxiety and cognition: insight from spatial and verbal working memory. Front Hum Neurosci, vol.7, 2013. ,
Cognitive Decline and Dementia Risk in Older Adults With Psychotic Symptoms: A Prospective Cohort Study, The American Journal of Geriatric Psychiatry, vol.21, issue.2, pp.119-147, 2013. ,
The Mild Behavioral Impairment Checklist (MBI-C): A rating scale for neuropsychiatric symptoms in pre-dementia populations, Journal of Alzheimer's disease : JAD, vol.56, issue.3, p.929, 2017. ,
Risk factors associated with the onset and progression of Alzheimer's disease: A systematic review of the evidence, Neurotoxicology, vol.61, pp.143-87, 2017. ,
Vitamin B12 for cognition, Database Syst Rev, issue.3, p.4326, 2003. ,
Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst Rev, vol.11, p.2854, 2012. ,
Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev, p.5562, 2012. ,
Introduction to Neuropsychopharmacology, vol.576, 2009. ,
CHAPTER 2 . 4 Acetylcholine : II . Nicotinic Receptors, 2018. ,
Cholinergic system during the progression of Alzheimer's disease: therapeutic implications, Expert Rev Neurother, vol.8, issue.11, pp.1703-1721, 2008. ,
Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease, Neurochem Int, vol.53, issue.5, pp.103-114, 2008. ,
Neurotransmitters and Novelty: A Systematic Review, J Psychopharmacol, vol.30, issue.1, pp.3-12, 2016. ,
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults, JAMA Neurol, vol.73, issue.6, pp.721-753, 201601. ,
More attention must be paid: the neurobiology of attentional effort, Brain Res Rev, vol.51, issue.2, pp.145-60, 2006. ,
Cholinergic enhancement modulates neural correlates of selective attention and emotional processing, Neuroimage, vol.20, issue.1, pp.58-70, 2003. ,
The cholinergic hypothesis of age and Alzheimer's diseaserelated cognitive deficits: recent challenges and their implications for novel drug development, J Pharmacol Exp Ther, vol.306, issue.3, pp.821-828, 2003. ,
The problems of anticholinergic adverse effects in older patients. Drugs Aging, vol.3, pp.335-383, 1993. ,
Anticholinergic Effects of Medication in Elderly Patients, J Clin Psychiatry, vol.62, pp.11-15, 2001. ,
Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review, Drugs Aging, vol.31, issue.3, pp.185-92, 2014. ,
The Influence of Patient Characteristics on Anticholinergic Events in Older People. Dement Geriatr Cogn Dis Extra, vol.5, pp.530-571, 2015. ,
Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study, Br J Clin Pharmacol, vol.59, issue.2, pp.143-51, 2005. ,
Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events, Am J Geriatr Pharmacother, vol.4, issue.1, pp.42-51, 2006. ,
Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry, vol.37, pp.293-300, 1980. ,
A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice, Psychopharmacol Bull, vol.36, issue.2, pp.24-39, 2002. ,
Association of low serum anticholinergic levels and cognitive impairment in elderly presurgical patients, Am J Psychiatry, vol.145, issue.3, pp.342-347, 1988. ,
Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study, Drugs Aging, vol.30, issue.5, pp.321-351, 2013. ,
The Anticholinergic Drug Scale as a Measure of Drug-Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity, The Journal of Clinical Pharmacology, vol.46, issue.12, pp.1481-1487, 2006. ,
A drug burden index to define the functional burden of medications in older people, Arch Intern Med, vol.167, issue.8, pp.781-788, 2007. ,
The anticholinergic risk scale and anticholinergic adverse effects in older persons, Arch Intern Med, vol.168, issue.5, pp.508-521, 2008. ,
Impact and Recognition of Cognitive Impairment among Hospitalized Elders, J Hosp Med, vol.5, issue.2, pp.69-75, 2010. ,
Anticholinergic Drug Burden in Older People's Brain -How well is it Measured?, Basic & Clinical Pharmacology & Toxicology, vol.114, issue.2, pp.151-160, 2014. ,
,
Impact of anticholinergics on the aging brain: a review and practical application. Aging Health, vol.4, pp.311-331, 2008. ,
Systematic review of anticholinergic risk scales in older adults, Eur J Clin Pharmacol, vol.69, issue.7, pp.1485-96, 2013. ,
Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study, Arch Intern Med, vol.169, issue.14, pp.1317-1341, 2009. ,
Use of anticholinergics and the risk of cognitive impairment in an African American population, Neurology, vol.75, issue.2, pp.152-161, 2010. ,
Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study, J Am Geriatr Soc, 2011. ,
Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women, Clin Pharmacol Ther, vol.83, issue.3, pp.422-431, 2008. ,
Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study, J Clin Psychopharmacol, vol.28, issue.6, pp.654-663, 2008. ,
Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study, J Am Geriatr Soc, vol.57, issue.3, pp.427-458, 2009. ,
Cognitive Decline in Older Persons Initiating Anticholinergic Medications, PLoS ONE ,
Cumulative anticholinergic exposure is associated with poor memory and executive function in older men, J Am Geriatr Soc, 2008. ,
Use of medications with anticholinergic properties and cognitive function in a young-old community sample, Int J Geriatr Psychiatry, vol.24, issue.6, pp.578-84, 2009. ,
Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders, vol.9, p.58, 2017. ,
Prescribing Practices of Anticholinergic Medications and Their Association With Cognition in an Extended Care Setting, J Appl Gerontol, vol.31, issue.2, pp.239-59, 2012. ,
Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes, Br J Clin Pharmacol, vol.75, issue.3, pp.842-851, 2013. ,
Long-term anticholinergic use and the aging brain, Alzheimers Dement, vol.9, issue.4, pp.377-85, 2013. ,
Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study, Drugs Aging, vol.30, issue.2, pp.103-115, 2013. ,
Effects of drug burden index on cognitive function in older men, J Clin Psychopharmacol, vol.32, issue.2, pp.273-280, 2012. ,
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI), Cochrane Database of Systematic Reviews ,
, , 2015.
Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study, Dement Geriatr Cogn Disord, vol.31, issue.3, pp.173-181, 2011. ,
Anticholinergic drugs in late life: adverse effects on cognition but not on progress to dementia, J Alzheimers Dis, vol.30, issue.2, pp.253-61, 2012. ,
Atropinic (anticholinergic) burden in antipsychotic-treated patients. Fundam Clin Pharmacol, 2009. ,
Associations between the Drug Burden Index, Potentially Inappropriate Medications and Quality of Life in Residential Aged Care, Drugs Aging, vol.35, issue.1, pp.83-91, 2018. ,
The French CONSTANCES populationbased cohort: design, inclusion and follow-up, Eur J Epidemiol, vol.30, issue.12, pp.1317-1345, 2015. ,
High quality standards for a large-scale prospective population-based observational cohort: Constances, vol.16, p.877, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01356135
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology, Pharmacoepidemiol Drug Saf, vol.26, issue.8, pp.954-62, 2017. ,
, Notre environnement : la Sécurité sociale
, SNDS : Système National des Données de Santé | CNIL
,
Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study, J Gerontol A Biol Sci Med Sci, vol.64, issue.4, pp.492-500, 2009. ,
Screening for dementia by memory testing, Neurology, vol.38, issue.6, pp.900-903, 1988. ,
Word fluency and brain damage. Neuropsychologia, vol.5, pp.135-175, 1967. ,
Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex ,
, Acta Neurol Belg, vol.90, issue.4, pp.207-224, 1990.
, Wechsler Adult Intelligence Scale-Revised. Psychological Corporation, 1981.
, The Fundamentals of Clinical Neuropsychiatry
Effect of age on performance of the Trail Making Test, Percept Mot Skills, vol.36, issue.3, pp.691-695, 1973. ,
The role of speed of processing, inhibitory mechanisms, and presentation order in trail-making test performance, Brain Cogn, vol.38, issue.2, pp.246-53, 1998. ,
A demographically based index of premorbid intelligence for the WAIS-R, Journal of Consulting and Clinical Psychology, vol.52, issue.5, pp.885-892, 1984. ,
Normative data for the Rappel libre/Rappel indicé à 16 items (16-item Free and Cued Recall) in the elderly Quebec-French population, Clin Neuropsychol, vol.28, issue.1, pp.1-19, 2015. ,
Anticholinergic burden: clinical implications for seniors and strategies for clinicians, Consult Pharm, vol.27, issue.8, pp.564-82, 2012. ,
Drugs with anticholinergic properties: a current perspective on use and safety, Expert Opinion on Drug Safety, vol.10, issue.5, pp.751-65, 2011. ,
Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: Références | 182 evidence from fMRI in healthy subjects, Eur Arch Psychiatry Clin Neurosci, 2012. ,
Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia, J Am Geriatr Soc, vol.62, issue.10, pp.1916-1938, 2014. ,
Atropinic burden of prescription forms in France: a study in community pharmacies in 2013, Eur J Clin Pharmacol, vol.70, issue.9, pp.1147-1155, 2014. ,
Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population, Pharmacotherapy, vol.36, issue.11, pp.1123-1154, 2016. ,
Pathophysiology of neuronal energy crisis in Alzheimer's disease. Neurodegener Dis, vol.5, pp.126-158, 2008. ,
Évaluation de la charge anticholinergique en gériatrie à l'aide de 3 échelles. NPG Neurologie -Psychiatrie -Gériatrie, vol.14, pp.81-88, 2014. ,
Benzodiazepine use and risk of Alzheimer's disease: case-control study, BMJ, vol.349, p.5205, 2009. ,
New Effect Size Rules of Thumb, Journal of Modern Applied Statistical Methods, vol.8, issue.2, pp.597-606, 2009. ,
Anticholinergic drug use is associated with episodic memory decline in older adults without dementia, Neurobiol Aging, vol.55, pp.27-32, 2017. ,
Adjusting for multiple testing-when and how, Journal of Clinical Epidemiology, vol.54, issue.4, pp.343-352, 2001. ,
Longterm cognitive impact of anticholinergic medications in older adults, Am J Geriatr Psychiatry, vol.14, issue.11, pp.980-984, 2006. ,
Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?, Eur J Clin Pharmacol, vol.71, issue.11, pp.1299-314, 2015. ,
Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis, Eur J Clin Pharmacol, vol.70, issue.2, pp.127-161, 2014. ,
Prescription Opioids and Risk of Dementia or Cognitive Decline: A Prospective Cohort Study, J Am Geriatr Soc, vol.63, issue.8, pp.1519-1545, 2015. ,
Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans, International Journal of Neuropsychopharmacology, vol.9, issue.2, pp.175-89, 2006. ,
,
Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohort, J Neurol Neurosurg Psychiatry, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02316638
Anticholinergic drugs and risk of dementia: case-control study, BMJ, vol.361, p.1315, 2018. ,
Cognitive dysfunction in unipolar depression: Implications for treatment, Journal of Affective Disorders, vol.152, pp.19-27, 2014. ,
Antipsychotic medication and cognitive function in schizophrenia, Schizophrenia Research, vol.86, issue.1, pp.138-184, 2006. ,
Depression, Cognitive Functions, and Impaired Functioning in Middle-Aged Adults From the CONSTANCES Cohort, J Clin Psychiatry, vol.79, issue.6, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02307478
Patterns and correlates of benzodiazepine use in the French general population, Eur J Clin Pharmacol, vol.60, issue.7, pp.523-532, 2004. ,
, médicale (Inserm) I national de la santé et de la recherche, Médicaments psychotropes : Consommations et pharmacodépendances
, Les éditions Inserm, pp.38-43, 2012.
The cognitive impact of anticholinergics: a clinical review, Clin Interv Aging, vol.4, pp.225-258, 2009. ,
Potentially procholinergic effects of medications commonly used in older adults, Am J Geriatr Pharmacother, vol.9, issue.1, pp.80-87, 2011. ,
Trajectories of Depressive Symptoms in Older Adults and Risk of Dementia, JAMA Psychiatry, vol.73, issue.5, pp.525-556, 201601. ,
Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia, J Clin Pharmacol, vol.56, issue.9, pp.1048-57, 2016. ,
Mild cognitive impairment: Long-term course of four clinical subtypes, Neurology, vol.67, issue.12, pp.2176-85, 2006. ,
Psychometric properties of the Center for Epidemiologic Studies Depression Scale (CES-D) in French clinical and nonclinical adults, Rev Epidemiol Sante Publique, vol.59, issue.5, pp.327-367, 2011. ,
Cholinergic medication for antipsychotic-induced tardive dyskinesia, Internet], 2018. ,
,
The Central Role of the Propensity Score in Observational Studies for Causal Effects, 1983. ,
,
A comparison of two methods of estimating propensity scores after multiple imputation, Stat Methods Med Res, vol.25, issue.1, pp.188-204, 2016. ,
Observational Research Using Propensity Scores. Adv Chronic Kidney Dis, vol.23, pp.367-72, 2016. ,
Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study, Neurology, vol.69, issue.19, pp.1859-67, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00169640
Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients, Pharmacopsychiatry, vol.35, issue.1, pp.6-11, 2002. ,
Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia, Journal of the International Neuropsychological Society, vol.14, issue.1, pp.110-118, 2008. ,
Cognitive function trajectories and their determinants in older people: 8 years of follow-up in the English Longitudinal Study of Ageing, J Epidemiol Community Health, vol.72, issue.8, pp.685-94, 2018. ,
Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study, PLoS Med, vol.16, issue.7, p.1002853, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02399913
Risk Factors for Late-Life Cognitive Decline and Variation with Age and Sex in the Sydney Memory and Ageing Study, PLoS One, vol.8, issue.6, 2013. ,
Successful aging: the contribution of early-life and midlife risk factors, J Am Geriatr Soc, vol.56, issue.6, pp.1098-105, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00291635
Social isolation, cognitive reserve, and cognition in healthy older people, PLoS One, 2018. ,
, Aug, vol.17, issue.8
Preventing Alzheimer's disease and cognitive decline, Evid Rep Technol Assess (Full Rep), issue.193, pp.1-727, 2010. ,
A nonlinear model with latent process for cognitive evolution using multivariate longitudinal data, Biometrics, vol.62, issue.4, pp.1014-1038, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00130040
The Use of Multiple Correspondence Analysis to Explore Associations between Categories of Qualitative Variables in Healthy Ageing, J Aging Res, p.302163, 2013. ,
Brain Disorders: Correlation between Cognitive Impairment and Complex Combination. Ment Health Fam Med, vol.12, 2016. ,
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients, J Gerontol A Biol Sci Med Sci, vol.72, issue.3, pp.395-402, 2017. ,
Standardized method to assess medicines' acceptability: focus on paediatric population, J Pharm Pharmacol, 2017. ,
Standardised evaluation of medicine acceptability in paediatric population: reliability of a model, J Pharm Pharmacol, vol.70, issue.1, pp.42-50, 2018. ,
A Decision Support Tool Facilitating Medicine Design for Optimal Acceptability in The Older Population, Pharm Res, vol.35, issue.7, p.136, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01793642
Dosage form suitability in vulnerable populations: A focus on paracetamol acceptability from infants to centenarians, PLoS One, vol.14, issue.8, 2019. ,
Sex Differences in Medicine Acceptability: A New Factor to Be Considered in Medicine Formulation, Pharmaceutics, vol.11, issue.8, 2019. ,
Acceptability of oral liquid pharmaceutical products in older adults: palatability and swallowability issues, BMC Geriatr, vol.19, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02922911
, Quelle place pour les benzodiazépines dans l'anxiété ?, HAS
, , 2018.
The Meaning and Strategic Use of Factor Analysis, Handbook of Multivariate Experimental Psychology ,
, Perspectives on Individual Differences, pp.131-203, 1988.
Principal component methods -hierarchical clustering -partitional clustering: why would we need to choose for visualizing data?, 2010. ,
Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses, Springer Series in Statistics, 2000. ,
Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort, vol.19, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02295511
A Comparison of Ten Methods for Determining the Number of Factors in Exploratory Factor Analysis, vol.39, p.15, 2013. ,
,
Smoking Is Associated With Abdominal Obesity, Not Overall Obesity, in Men With Type 2 Diabetes, J Prev Med Public Health, vol.45, issue.5, pp.316-338, 2012. ,
Associations between loneliness and perceived social support and outcomes of mental health problems: a systematic review, BMC Psychiatry [Internet], vol.18, 2018. ,
Benzodiazepine use and risk of dementia: prospective population based study. The BMJ [Internet, vol.345, 2012. ,
Anxiety as a Predictor for Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis ,
, The American Journal of Geriatric Psychiatry, vol.24, issue.10, pp.823-865, 2016.
Cognitive profile in CADASIL, Neurosurgery & Psychiatry, vol.77, issue.2, pp.175-80, 2006. ,
Neuropsychiatric symptom clusters targeted for treatment at earlier versus later stages of dementia, International Journal of Geriatric Psychiatry, vol.30, issue.4, pp.357-67, 2015. ,
Cognitive effects of long-term benzodiazepine use: a meta-analysis, CNS Drugs, vol.18, issue.1, pp.37-48, 2004. ,
The effects of benzodiazepines on cognition, J Clin Psychiatry, vol.66, issue.2, pp.9-13, 2005. ,
Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol, vol.19, pp.437-54, 2004. ,
The risk of cognitive impairment in older community-dwelling women after benzodiazepine use, Age Ageing, vol.38, issue.2, pp.226-234, 2009. ,
Benzodiazepine use and cognitive decline in elderly with normal cognition, vol.30, p.113, 2016. ,
Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial, JAMA Intern Med, vol.174, issue.6, pp.890-898, 2014. ,
The association between cognition and histamine-2 receptor antagonists in African Americans, J Am Geriatr Soc, vol.55, issue.8, pp.1248-53, 2007. ,
Drug burden index score and functional decline in older people, Am J Med, 2009. ,
,
Use of drugs with anticholinergic effects and cognitive impairment in community-living older persons, Age Ageing, 2009. ,
The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study. Age Ageing, vol.40, pp.730-735, 2011. ,
Effect of Anticholinergic Use for the Treatment of Overactive Bladder on Cognitive Function in Postmenopausal Women, Clin Drug Investig, vol.32, issue.10, pp.697-705, 2012. ,
, Influence of Antipsychotic and Anticholinergic Loads on Cognitive Functions in Patients with Schizophrenia
, Schizophrenia Research and Treatment, 2016.
Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study, Geriatr Gerontol Int, vol.13, issue.3, pp.694-700, 2013. ,
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study, JAMA Intern Med, vol.179, issue.8, pp.1084-93, 2019. ,
Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psychopharmacology (Berl), vol.169, pp.404-415, 2003. ,
Assessment of cognitive function of the elderly population: effects of darifenacin, J Urol, vol.173, issue.2, pp.493-501, 2005. ,
Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects, Eur Urol, vol.50, issue.2, pp.317-343, 2006. ,
Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg, Expert Opin Drug Saf, vol.8, issue.6, pp.615-641, 2009. ,
689 Solifenacin and cognitive function in elderly people with mild cognitive impairment: The SENIOR study, European Urology Supplements, vol.11, issue.1, pp.689-689, 2012. ,
Cognitive impact of anticholinergic medication in MS: Adding insult to injury? Mult Scler Relat Disord, vol.1, pp.156-61, 2012. ,
Cognitive burden of anticholinergic medications in psychotic disorders, vol.190, p.129, 2017. ,